Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol

J Assist Reprod Genet. 2007 Aug;24(8):326-30. doi: 10.1007/s10815-007-9125-x. Epub 2007 Jul 17.

Abstract

Purpose: The purpose of the study was to compare the effectiveness of GnRH antagonist with luteal phase estradiol administration to GnRH agonist cycles, long protocol.

Methods: 55 IVF-ICSI patients received oestradiol in the luteal phase of the cycle, before a cycle with GnRH antagonist. Fifty-five patients submitted to IVF-ICSI with the use of agonist were allocated, age matched, as a control group (historical control). The primary outcome was the number of retrieved oocytes.

Results: Patients were similar in terms of clinical characteristics. No differences were found in the number of oocytes retrieved (study group, 8.1 +/- 4.7; control group, 7.4 +/- 4.5) or in oocyte quality.

Conclusions: We clearly demonstrated that the effectiveness of GnRH antagonist when combined with luteal phase estradiol is comparable to GnRH agonist cycles.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Case-Control Studies
  • Chorionic Gonadotropin / pharmacology
  • Embryo Implantation / drug effects
  • Embryo Implantation / physiology*
  • Estradiol / administration & dosage*
  • Female
  • Fertilization in Vitro
  • Gonadotropin-Releasing Hormone / agonists*
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors*
  • Humans
  • Leuprolide / administration & dosage*
  • Luteal Phase / drug effects*
  • Luteal Phase / metabolism
  • Oocytes / drug effects*
  • Ovulation Induction*
  • Pregnancy
  • Sperm Injections, Intracytoplasmic

Substances

  • Chorionic Gonadotropin
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Leuprolide